Revance Therapeutics - Daily Chart

Name
*Data as of: 2017-09-22
Company Summary Revance Therapeutics, Inc. is a biopharmaceutical company which focuses on the development, manufacture and commercialization of novel botulinum toxin products for various aesthetic and therapeutic applications. The company's technology platform includes TransMTS (R). Its lead product candidate consists of RT001, a topical gel formulation of botulinum toxin type A, which is in Phase III clinical trials for the treatment of crow's feet lines; has completed initial Phase II clinical trials for the treatment of hyperhidrosis and for the prevention of migraine headache; and has completed Phase I clinical trials for the treatment of other indications, such as neuropathic pain and rhinitis. The company is also developing RT002, a novel injectable formulation of botulinum toxin type A, which is being tested in the four-cohort Phase I/II clinical dose escalation trials for the treatment of glabellar lines. Revance Therapeutics, Inc. is based in Newark, United States.
Daily Stock Data   Dates and Ratios   Company Background
Symbol RVNC Earnings Date 2017-11-03 Exchange NASDAQ
Name Revance Therapeutics Ex Dividend Date N/A Sector Medical
Close $24.10 Exp. Dividend Amount N/A Industry Medical - Biomed / Biotech
$ Change
-0.25
Dividend Yield 0.00 Market Cap 743M
% Change
-1.00%
Alpha 0.06 Enterprise Value 581M
Open 24.25 Beta 2.11 Shares 1000s 30,819
Days Range 23.70 - 24.40 Daily ATR 0.83 Incorp Date 1999
52 Week Range 12.35 - 28.30 Daily ATR% 3.42% IPO Date 2014-02-06
Volume 100,100 Price/Earnings 0.00 Location Newark,CA
Avg Vol 50d 150,390 Price/Book 4.19 ADR No
Vol % Chg vs 50 Day
-33.50%
Price/Sales 2321.06 Options Yes
Up/Down Volume 0.90 PEG 0.00 ETF/Closed End Fund No
AD Rating Timeliness Rating Industry Group Rank
Symbol Comp Rating EPS Rating SMR Rating RS Rating Sponsor Rating Current Last Week Current Last Week Ind Group RS Current Last Week 3 Months Ago 6 Months Ago Industry Group Sector
RVNC 43 7 E 69 B B B C C A+ 6 7 20 7 Medical-Biomed/Biotech MEDICAL
   
Stock Symbol   Sector   Industry Group
RVNC   Medical   Medical - Biomed / Biotech
Overall Stock Ratings   Stock Ratings within Sector   Stock Ratings within Industry
Full 7.97 Full 5.59023 Full 3.37
Earnings 9.65 Earnings 23.63 Earnings 33.71
Sales 0.02 Sales 0.13 Sales 0.22
Margins 13.61 Margins 33.04 Margins 40.90
Valuation 81.56 Valuation 75.09 Valuation 71.46
Best Rated Stocks Overall   Best Rated Stocks in Sector:
Medical
  Best Rated Stocks in Industry:
Medical - Biomed / Biotech
JP 100.00 CORT 100.00 CORT 100.00
YY 99.98 LMAT 99.87 CELG 99.78
ESNT 99.96 ABMD 99.75 SUPN 99.55
FB 99.94 HSKA 99.62 BIVV 99.33
NVMI 99.92 ALGN 99.49 VRTX 99.10
*All ratings range from 0 to 100 with 100 being the highest.
 
Stock Symbol   Sector   Industry Group
RVNC   Medical   Medical - Biomed / Biotech
% Gain   Average Stock Gain % in Sector   Average Stock Gain % in Industry
1 Day
-1.00%
1 Day
+0.25%
1 Day
-0.09%
1 Week
-2.03%
1 Week
-0.33%
1 Week
+0.50%
2 Weeks
-5.86%
2 Weeks
+0.16%
2 Weeks
+0.66%
3 Weeks
-1.83%
3 Weeks
+1.73%
3 Weeks
+1.49%
1 Month
+6.87%
1 Month
+5.44%
1 Month
+10.25%
3 Months
-8.71%
3 Months
+2.79%
3 Months
+10.55%
6 Months
+21.41%
6 Months
+15.31%
6 Months
+26.10%
1 year
+44.23%
1 year
+19.02%
1 year
+28.01%
YTD
+16.43%
YTD
+25.76%
YTD
+42.60%
 
Sector Info   Sector Ranking   Average Stock Gain % in Sector
Symbol RVNC Current 19 1 Day
+0.25%
Sector Medical Yesterday 19 1 Week
-0.33%
Market Val(Bil) 4,464.64B 1 Week Ago 15 2 Weeks
+0.16%
Industry Groups 445 2 Week Ago 9 3 Week
+1.73%
Total Stocks 787 3 Week Ago 12 1 Month
+5.44%
New Highs 27 1 Month Ago 15 3 Month
+2.79%
New Highs % 3.43% 3 Month Ago 5 6 Months
+15.31%
New Lows 13 6 Month Ago 29 1 year
+19.02%
New Lows % 1.65% 1 Year Ago 27 YTD
+25.76%
 
Industry Group Info   Industry Group Ranking   Average Stock Gain % in Industry
Symbol RVNC Current 24 1 Day
-0.09%
Industry Group Medical - Biomed / Biotech Yesterday 23 1 Week
+0.50%
Market Val(Bil) 888.06B 1 Week Ago 21 2 Weeks
+0.66%
Total Stocks 445 2 Weeks Ago 16 3 Weeks
+1.49%
New Highs 15 3 Weeks Ago 13 1 Month
+10.25%
New Highs % 3.37% 1 Month Ago 24 3 Months
+10.55%
New Lows 10 3 Months Ago 19 6 Months
+26.10%
New Lows % 2.25% 6 Months Ago 115 1 Year
+28.01%
      1 Year Ago 111 YTD
+42.60%
Data as of: 2017-09-22
Daily Stock Data   Dates and Ratios   Company Background
Symbol RVNC Earnings Date 2017-11-03 Exchange NASDAQ
Name Revance Therapeutics Ex Dividend Date N/A Sector MEDICAL
Close 24.1 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change -0.25 Dividend Yield 0 Market_Cap_mil 742.7
% Change -1 Alpha 0.06 Enterprise_Val_mil 580.7
Open 24.25 Beta 2.11 Shares_1000s 30819
Day's Range 23.7 - 24.4 Daily ATR 0.83 Incorp_Date 1999
52 Week Range 12.35 - 28.3 Daily ATR% 3.42 IPO Date 2014-02-06
Volume 10,010,000 Price/Earnings Location Newark,CA
Avg Vol 50d 15,039,000 Price/Book 4.19 ADR No
Short Volume 4,226,713 Price/Sales 2321.06 Options Yes
Shrt Int Pcnt Chg 7.4 PEG ETF/Closed End Fund No
Data as of: 2017-09-22
Daily Stock Data   Dates and Ratios   Company Background
Symbol RVNC Earnings Date 2017-11-03 Exchange NASDAQ
Name Revance Therapeutics Ex Dividend Date N/A Sector MEDICAL
Close 24.1 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change -0.25 Dividend Yield 0 Market_Cap_mil 742.7
% Change -1 Alpha 0.06 Enterprise_Val_mil 580.7
Open 24.25 Beta 2.11 Shares_1000s 30819
Day's Range 23.7 - 24.4 Daily ATR 0.83 Incorp_Date 1999
52 Week Range 12.35 - 28.3 Daily ATR% 3.42 IPO Date 2014-02-06
Volume 10,010,000 Price/Earnings Location Newark,CA
Avg Vol 50d 15,039,000 Price/Book 4.19 ADR No
Short Volume 4,226,713 Price/Sales 2321.06 Options Yes
Shrt Int Pcnt Chg 7.4 PEG ETF/Closed End Fund No
Sales Ratings (0 to 10) Sales Accelerating % Sales Growth % Sales Growth Rank
Symbol Overall within Sector within Industry Annual Sales 2Q 3Q Last Qtr Last Yr 3 Years 5 Years Last Qtr Last Yr 3 Years 5 Years
RVNC 0.02 0.13 0.22 0.3M No No 0 0 -19 -19
Data as of: 2017-09-22
Daily Stock Data   Dates and Ratios   Company Background
Symbol RVNC Earnings Date 2017-11-03 Exchange NASDAQ
Name Revance Therapeutics Ex Dividend Date N/A Sector MEDICAL
Close 24.1 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change -0.25 Dividend Yield 0 Market_Cap_mil 742.7
% Change -1 Alpha 0.06 Enterprise_Val_mil 580.7
Open 24.25 Beta 2.11 Shares_1000s 30819
Day's Range 23.7 - 24.4 Daily ATR 0.83 Incorp_Date 1999
52 Week Range 12.35 - 28.3 Daily ATR% 3.42 IPO Date 2014-02-06
Volume 10,010,000 Price/Earnings Location Newark,CA
Avg Vol 50d 15,039,000 Price/Book 4.19 ADR No
Short Volume 4,226,713 Price/Sales 2321.06 Options Yes
Shrt Int Pcnt Chg 7.4 PEG ETF/Closed End Fund No
Margins Ratings (0 to 10) Average After Tax Margins
Symbol Overall within Sector within Industry Pretax Margin Last Qtr After Tax Margin Accel 3Q After Tax Margin Last Qtr 2 Qtr 3 Qtr 4 Qtr 5 Qtr 6 Qtr
RVNC 13.61 33.04 40.9 -26736.7 No
 
Stock Symbol   Sector   Industry Group
RVNC   Medical   Medical - Biomed / Biotech
Ratios   Average Ratios in Sector   Average Ratios in Industry
Price/Earnings (PE) 0.00 Price/Earnings (PE) 50.55 Price/Earnings (PE) 98.02
Price/Book (PB) 4.19 Price/Book (PB) 2.25 Price/Book (PB) 4.49
Price/Sales (PS) 2321.06 Price/Sales (PS) 207.41 Price/Sales (PS) 394.44
Price/Cash Flow (PCF) -12.41 Price/Cash Flow (PCF) -1.44 Price/Cash Flow (PCF) -9.70
PEG 0.00 PEG 2.54 PEG 0.71
Dividend Adj PEG 0.00 Dividend Adj PEG 2.26 Dividend Adj PEG 0.70
Return on Equity (ROE) -37.30 Return on Equity (ROE) -102.42 Return on Equity (ROE) -126.70
Yield 0.00 Yield 1.00 Yield 1.42
Current Ratio 7.93 Current Ratio 5.72 Current Ratio 7.34
Debt % 1.10% Debt % 83.30% Debt % 45.20%
Long Term Debt/Work Capital 0.00 Long Term Debt/Work Capital 1.03 Long Term Debt/Work Capital 0.24
 
Stock RVNC   Exponential Moving Averages   Simple Moving Averages
Name Revance Therapeutics EMA 10 days
24.34(-0.99%)
SMA 10 days
24.44(-1.39%)
Close $24.10 EMA 20 days
24.27(-0.7%)
SMA 20 days
24.39(-1.19%)
$ Change
-0.25
EMA 50 days
23.97(0.54%)
SMA 50 days
23.66(1.86%)
% Change
-1.00%
EMA 89 days
23.49(2.6%)
SMA 79 days
24.23(-0.54%)
Volume 100,100 EMA 100 days
23.34(3.26%)
SMA 100 days
23.49(2.6%)
Avg Volume 150,390 EMA 200 days
22.14(8.85%)
SMA 200 days
21.95(9.79%)
Vol% vs. Avg Vol
-33.50%
           
Up/Down Vol 0.90   Keltner Channel   Bollinger Band
Distribution Days 5   Upper
25.39(-5.08%)
  Upper
25.81(-6.63%)
ATR 0.83   Mid
24.31(-0.86%)
  Mid
24.39(-1.19%)
ATR% 3.42%   Lower
23.24(3.7%)
  Lower
22.96(4.97%)